A retrospective analysis of treatment responses of palmoplantar psoriasis in 114 patients
- 3 June 2009
- journal article
- Published by Wiley in Journal of the European Academy of Dermatology and Venereology
- Vol. 23 (7), 814-819
- https://doi.org/10.1111/j.1468-3083.2009.03197.x
Abstract
Treatment options remain unsatisfactory for patients with palmoplantar psoriasis (PP) and palmoplantar pustular psoriasis (PPP). Aim To evaluate the therapeutic responses of PP and PPP patients that were treated in our psoriasis polyclinic between 2003 and 2007. This retrospective study comprised PP (n = 62) and PPP (n = 52) patients. Treatments were individualized according to patient compliance and associating systemic diseases. The effect of systemic treatments was grouped as follows: 'no improvement': patients unresponsive for the present treatment; 'partial improvement': < 50% decrease in severity or affected area; 'moderate improvement': 50-75% decrease in severity or affected area, and 'marked improvement': > 75% decrease of the disease compared to baseline. In the PP group, 17 of 62 patients showed marked improvement to topical agents, while the remaining patients required systemic agents including oral retinoids (n = 24), local psoralen plus ultraviolet A (PUVA; n = 12), methotrexate (n = 9) and cyclosporine (n = 2). Marked improvement was achieved in 53%, 45%, 47% and 100%, respectively. In these patients, two (n = 10), three (n = 5), or four (n = 5) systemic agents were used alternately. In the PPP group, 18 of 52 patients achieved marked improvement by topical agents. Patients that required systemic agents were treated with colchicum (n = 19), local PUVA (n = 8), methotrexate (n = 4), oral retinoids (n = 3) and cyclosporine (n = 2). These treatments achieved a marked improvement in 60%, 33%, 57%, 83%, and 50% of the patients, respectively. In the course of the disease, 18 patients required two and 3 patients required three systemic agents alternately. Although the success rates appeared to be high, the high number of patients who required multiple systemic agents emphasized the fact that localized forms of psoriasis were resistant to therapy.Keywords
This publication has 32 references indexed in Scilit:
- Topical 5‐aminolaevulinic acid photodynamic therapy for intractable palmoplantar psoriasisThe Journal of Dermatology, 2006
- Psoralen cream plus ultraviolet A photochemotherapy (PUVA cream): our experienceJournal of the European Academy of Dermatology and Venereology, 2006
- PUVA-gel vs. PUVA-bath therapy for severe recalcitrant palmoplantar dermatoses. A randomized, single-blinded prospective studyPhotodermatology, Photoimmunology & Photomedicine, 2005
- Retrospective analysis of the treatment of psoriasis of the palms and solesJournal of Dermatological Treatment, 2003
- PUVA-bath photochemotherapy (PUVA-soak therapy) of recalcitrant dermatoses of the palms and solesPhotodermatology, Photoimmunology & Photomedicine, 1999
- Generalized pustular psoriasis following withdrawal of oral cyclosporin treatment for palmo-plantar pustulosisClinical and Experimental Dermatology, 1999
- Topical Psoralen-Ultraviolet A Therapy for Palmoplantar Dermatoses: Experience With 35 Consecutive PatientsMayo Clinic Proceedings, 1998
- Occlusive treatment of palmoplantar pustular psoriasis with clobetasol propionate ointment succeeded by short-term PUVAJournal of Dermatological Treatment, 1995
- The efficacy of localized PUVA therapy for chronic hand and foot dermatosesClinical and Experimental Dermatology, 1994
- CorrespondenceBritish Journal of Dermatology, 1982